Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vulcan Infrastructure & Power Inc.Greenidge Generation Holdings Reports Net Income Turnaround in Q3 2025
Candel Therapeutics, Inc.Candel Therapeutics Reports $8.7 Million Net Loss for Nine Months Ended September 30, 2025
Ondas Inc.Ondas Holdings Reports 581% Revenue Growth to $10.1 Million in Latest Quarter
MIDDLEFIELD BANC CORPMiddlefield Banc Corp. Reports 127.4% Increase in Q3 Net Income, Announces Merger with Farmers National Banc Corp.
Mastech Digital, Inc.Mastech Digital Reports Revenue Decline and Net Loss in Q3 2025
Vivani Medical, Inc.Vivani Medical Reports $6.5 Million Net Loss in Q3 2025, Focuses on Product Development
Bitcoin Depot Inc.Bitcoin Depot Reports 20.1% Revenue Growth to $162.5 Million in Latest Quarter
Odysight.ai Inc.Odysight.ai Reports 3% Revenue Decline and Increased Operating Loss for Nine Months Ending September 30, 2025
Synergy CHC Corp.Synergy CHC Corp. Reports Q3 2025 Revenue Growth to $8.01 Million, Net Income Decline
Monopar TherapeuticsMonopar Therapeutics Reports Increased Losses and Cash Surge in Q3 2025
Healthcare Triangle, Inc.Healthcare Triangle Reports 45% Revenue Growth but Incurred $1.91 Million Net Loss in Latest Quarter
NORTECH SYSTEMS INCNortech Systems Reports Decline in Q3 2025 Sales, Despite Increased Gross Profit
Imunon, Inc.Imunon Reports $3.4 Million Net Loss in Q3 2025, Seeks Funding for Clinical Trials
Clene Inc.Clene Inc. Reports 83% Revenue Decline in Q3 2025, Faces Financial Challenges
TaoWeave, Inc.Oblong, Inc. Reports 4% Revenue Increase to $601,000 in Q3 2025, Faces $2.29 Million Net Loss
Xilio Therapeutics, Inc.Xilio Therapeutics Reports $19.1 Million Revenue for Q3 2025, Net Loss Increases to $16.3 Million
Century Therapeutics, Inc.Century Therapeutics Reports $34.4 Million Net Loss in Q3 2025
Sagimet Biosciences Inc.Sagimet Biosciences Reports Q3 2025 Financial Results with $12.9M Net Loss
Worksport LtdWorksport Ltd. Reports 61% Revenue Growth in Q3 2025 Despite Increased Net Loss
Grace Therapeutics, Inc.Grace Therapeutics Reports Reduced Net Loss and Focus on GTx-104 Development
MIRA PHARMACEUTICALS, INC.Mira Pharmaceuticals Reports Significant Asset Growth and Ongoing Losses in Q3 2025
Sunrise Realty Trust, Inc.Sunrise Realty Trust Reports Significant Financial Growth with $4.1M Net Income in Latest Quarter
FITLIFE BRANDS, INC.FitLife Brands Reports 47% Revenue Growth in Q3 2025, Net Income Declines
Traws Pharma, Inc.Traws Pharma Reports No Revenue for Q3 2025, Net Loss Improves to $3.96 Million
Arbutus Biopharma CorpArbutus Biopharma Reports Q3 2025 Revenue Decline, Significant Nine-Month Revenue Increase